Search

everythinglearnresearchcommunity

for

Search:↓

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

Dutasteride and finasteride affect different cell types differently.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Researchers found specific genes in the part of hair follicles that could help treat hair disorders.

Double-stranded RNA activates a pathway that causes a skin protein to be expressed in the wrong place.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

Blocking a specific protein signal can make hair grow on mouse nipples.

Certain genes are linked to type 1 and type 2 diabetes in kids, and changes in these genes can also cause other diabetes-related conditions.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Ectoin helps prevent cortisone-induced skin problems and supports skin health.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Lithocholic acid helps hair growth and regeneration in alopecia by activating vitamin D receptors.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Nicotinic acid reduces excessive oil production in skin cells by activating a specific receptor, which could help treat acne.

RANK-RANKL signaling is essential for hair growth and skin health.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Claudin-1 and Claudin-3 are crucial for keeping hair follicle structure and preventing a type of hair loss called telogen effluvium.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

Panax ginseng extract may help prevent hair loss caused by DKK-1.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.